Arm Holdings CEO Rene Haas told CNBC's Jim Cramer that his confidence in reaching $2 billion in revenue for the company's new AGI CPU has increased since the July earnings call. Arm first flagged $2 billion in demand visibility in May, double its earlier $1 billion estimate, but had held off raising guidance while working to secure sufficient manufacturing capacity.
Rene Haas, chief executive of Arm Holdings, told the BBC that AI will eventually cure cancer by modelling complex cellular and DNA processes beyond current human or computing capability, though he said this progress is being constrained by a shortage of chips needed to build data centres. He also predicted humanoid robots would become widespread within five years, while expressing doubt that chip manufacturing could realistically be built up in the UK.
Proxy advisers ISS and Glass Lewis are recommending investors vote down a proposed $800 million performance-based compensation package for Arm CEO Rene Haas ahead of the company's September 9 annual meeting. The award consists of 425,000 performance share units split into three tranches tied to Arm hitting market capitalizations of $1 trillion, $1.5 trillion, and $2 trillion by 2029-2031, with Arm currently valued near $250 billion.